Johnson & Johnson to Participate in the 2024 Cantor Global Healthcare Conference

JNJ

New Brunswick, N.J- Johnson & Johnson (NYSE: JNJ) will participate in the 2024 Cantor Global Healthcare Conference on Wednesday, September 18th, at the InterContinental Barclay Hotel in New York. Peter Fang, Worldwide Vice President, Neuroscience and Bill Martin, Global Therapeutic Area Head Neuroscience, will represent the Company in a session scheduled at 11:30 a.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

Media contact:

media-relations@its.jnj.com

Investor contact:

investor-relations@its.jnj.com

(C) 2024 Electronic News Publishing, source ENP Newswire